11 May 2016
As pharma continues to grow and evolve, our expert company analysts will help you to assess and compare industry players in terms of sales growth, therapeutic focus, launch/expiry balance, diversification, and profitability. They specialize in providing strategic recommendations to manage generic threats, enhance cost-efficiencies, and exploit potential growth opportunities.
Explore the pipelines, performances, and future prospects of companies across the full spectrum of the pharma industry, from leading pharma players and major generics companies to emerging biopharmas at the forefront of innovation. Use our industry-leading company data analyzer to compare metrics across competitors of your choice, and take full advantage of our new and expanded coverage of the lucrative biosimilars space.
I recommend Datamonitor Healthcare: for its broad coverage of indications and companies; because it is very useful in discovering new geographical areas, new therapeutical areas, and big companies’ key figures and issues; and for its updated analysis on pipelines. As a competitive intelligence manager, Datamonitor Healthcare reports are essential.
Business Analyst, STALLERGENES
Leading Pharma Companies
Review the performances and prospects of the top 50 pharma and biotech companies, using our 5-year revenue projections and analysis of key growth drivers and resistors facing each developer. Our insights will allow you to identify how revenue contributions will evolve through launch, core, and expiry portfolios, and monitor shifts in companies’ therapy focus as they look to target profitable areas with unmet needs.
Generics and Biosimilars
As these fast-moving markets continue to evolve, our analysis will identify the opportunities and threats posed by key developers in the space, in addition to assessing the potential for strategic licensing and partnership agreements. Our coverage will extend to include the 10 leading companies from both the biosimilars and generics sectors, with detailed insights relating to their pipelines, geographic reach, and business strategies.
Emerging Pharma Companies
Study detailed profiles of key emerging companies with some of the most talked about pipeline candidates in the industry. Our coverage of their market strategies, company-reported sales-based forecasts, and in-depth financial analyses will provide you with a complete perspective of each company’s positioning and outlook.
The pharmaceutical industry is one of the most dynamic in the world. See how evolving market dynamics are set to change the landscape of the industry completely, and understand how burgeoning trends will shape companies’ performances in the years to come. With the impact of key industry events forecast over a 5-year period – including era-defining M&A deals, major regulatory controversies, and shock trial results – you’ll always be one step ahead of the competition.